RxDoctor Payments Data

Sandra Barrett

Family · Murfreesboro, TNNPI 1851632947

Payments from drug & device makers

$548in general payments, 2019–2025

Across 30 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$101
  • Novo Nordisk$76
  • Abbott$76
  • Lilly USA, LLC$65
  • Amgen$63
  • Gilead$34
  • plus $134 from 7 others

What the payments were for

  • Food & beverage$548100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$548 in reported general payments places this provider in the 50th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$31,156
Medicare patients
148
Services billed
659

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide16$16,550
FarxigaDapagliflozin Propanediol15$12,593
EliquisApixaban18$11,891
Atorvastatin Calcium73$1,191
Metformin Hcl39$534
Escitalopram Oxalate41$459
Albuterol Sulfate HfaAlbuterol Sulfate17$455
Levothyroxine Sodium43$450
Omeprazole26$426
Fluticasone Propionate14$377
Amlodipine Besylate41$371
Duloxetine Hcl17$363
Famotidine16$338
Losartan Potassium23$291
Carvedilol14$209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$65$16,55016 claims
AstraZenecaFarxiga$16$12,59315 claims
PfizerEliquis$21$11,89118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,706 family providers in Tennessee.

Other family in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →